HCA Healthcare, Inc. HCA | NYSE

$303.62 $6.10 | 2.05%

After Hours
$303.5 -$0.12 | -0.04%

Next Earnings: Jan 28, 2025

Company Overview:

Market Cap: $76.91B
PE Ratio: 13.63
52-Week Range: $268.01 - $417.14
Dividend Yield (FWD): 0.87% ($2.64)

10 Year Performance Metrics:

Total Return (with DRIP): 330.03% (15.70% / yr)
Total Return (no DRIP): 320.12% (15.43% / yr)
Share Price: 305.04%
Dividend Increase: 88.57%
HCA 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

HCA Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
HCA Dividend CAGR:1Y: 10.00%2Y: 8.56%5Y: 10.53%10Y: N/A
Share Price
HCA Price CAGR:1Y: 15.24%2Y: 12.86%5Y: 15.53%10Y: 15.09%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

HCA Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - HCA
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - HCA
14-Day FREE Trial Get Full Access Now!

HCA Earnings, Revenue, Cash & Debt, Shares Outstaning:

HCA - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
HCA - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HCA - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HCA - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
HCA - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
HCA - Cash & Debt
14-Day FREE Trial Get Full Access Now!
HCA - Revenue
14-Day FREE Trial Get Full Access Now!
HCA Revenue CAGR:1Y: 7.86%2Y: 8.08%5Y: 6.62%10Y: 6.61%
HCA - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
HCA EPS CAGR:1Y: 24.74%2Y: 11.83%5Y: 22.68%10Y: 15.47%
HCA - Net Income
14-Day FREE Trial Get Full Access Now!
HCA Net Income CAGR:1Y: 17.70%2Y: 5.83%5Y: 15.72%10Y: 9.38%
HCA - EBITDA
14-Day FREE Trial Get Full Access Now!
HCA EBITDA CAGR:1Y: 13.30%2Y: 6.04%5Y: 7.39%10Y: 5.97%
HCA - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
HCA Free Cash Flow CAGR:1Y: 74.47%2Y: 10.92%5Y: 18.68%10Y: 15.31%
HCA - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
HCA Free Cash Flow / Share CAGR:1Y: 84.27%2Y: 17.05%5Y: 25.54%10Y: 21.51%
HCA - Gross Profit
14-Day FREE Trial Get Full Access Now!
HCA Gross Profit CAGR:1Y: 7.49%2Y: 8.27%5Y: 6.94%10Y: 6.80%
HCA - Expenses
14-Day FREE Trial Get Full Access Now!
HCA Expenses CAGR:1Y: 3.84%2Y: 2.62%5Y: 0.90%10Y: 7.67%
HCA - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
HCA Shares Outstanding CAGR:1Y: -5.63%2Y: -5.30%5Y: -5.64%10Y: -5.28%
HCA - Share Buybacks
14-Day FREE Trial Get Full Access Now!
HCA Share Buybacks CAGR:1Y: 57.46%2Y: 60.36%5Y: 49.67%10Y: N/A
HCA - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
HCA Stock-Based Comp CAGR:1Y: 5.56%2Y: -6.54%5Y: -6.26%10Y: 6.37%
HCA - Dividends
14-Day FREE Trial Get Full Access Now!
HCA Dividend CAGR:1Y: 10.00%2Y: 8.56%5Y: 10.53%10Y: N/A
HCA - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
HCA Revenue CAGR:1Y: 7.86%2Y: 8.08%5Y: 6.62%10Y: 6.61%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

HCA - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HCA Actual Revenue CAGR:1Y: 7.86%2Y: 8.08%5Y: 6.62%10Y: 6.61%
HCA - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HCA Actual EPS CAGR:1Y: 24.74%2Y: 11.83%5Y: 22.68%10Y: 15.47%
HCA - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HCA Actual Net Income CAGR:1Y: 17.70%2Y: 5.83%5Y: 15.72%10Y: 9.38%
HCA - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HCA Actual EBITDA CAGR:1Y: 13.30%2Y: 6.04%5Y: 7.39%10Y: 5.97%

Ratios, Profit Margins & Return on Capital:

HCA - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
HCA Net Profit Margin CAGR:1Y: 9.01%2Y: -2.07%5Y: 8.54%10Y: 2.59%
HCA - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
HCA Gross Profit Margin CAGR:1Y: -0.33%2Y: 0.18%5Y: 0.30%10Y: 0.18%
HCA - Price to Earnings
14-Day FREE Trial Get Full Access Now!
HCA - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
HCA - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
HCA - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

HCA Dividends Info:

Annual Dividend: $2.64
Forward Yield: 0.87%
Ex-Dividend Date: 2024-12-13
Lifetime Dividens / Share: $19.47

HCA Dividend History: Dates, Payments & Yield list

Below is a schedule of all HCA dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
12/13/202412/27/2024$0.6600.84%0.84%$313.93
09/16/202409/30/2024$0.6600.64%0.65%$403.43
06/14/202406/28/2024$0.6600.75%0.78%$337.47
03/14/202403/29/2024$0.6600.76%0.81%$324.78
12/13/202312/28/2023$0.6000.89%0.89%$268.27
09/14/202309/29/2023$0.6000.9%0.91%$263.58
06/15/202306/30/2023$0.6000.81%0.84%$285.89
03/16/202303/31/2023$0.6000.9%0.94%$254.38
12/13/202212/28/2022$0.5600.92%0.92%$243.10
09/15/202209/30/2022$0.5601.03%1.07%$208.97
06/15/202206/30/2022$0.5601.14%1.23%$181.69
03/16/202203/31/2022$0.5600.75%0.84%$266.35
12/13/202112/29/2021$0.4800.79%0.79%$244.10
09/15/202109/30/2021$0.4800.67%0.75%$256.45
06/15/202106/30/2021$0.4800.62%0.92%$209.56
03/16/202103/31/2021$0.4800.44%1.03%$185.52
12/24/202001/13/2021$0.2680.47%0.65%$164.24
10/29/202011/12/2020$0.0720.72%0.23%$125.40
02/28/202003/31/2020$0.4301.28%1.35%$127.01
11/29/201912/27/2019$0.4001.15%1.15%$138.66
08/30/201909/30/2019$0.4001.29%1.33%$120.20
05/31/201906/28/2019$0.4001.24%1.32%$120.96
02/28/201903/29/2019$0.4001.04%1.15%$139.04
11/30/201812/28/2018$0.3500.97%0.97%$143.99
08/31/201809/28/2018$0.3500.78%1.04%$134.11
05/31/201806/29/2018$0.3500.68%1.36%$103.14
02/28/201803/30/2018$0.3500.35%1.41%$99.25
12/13/201212/21/2012$2.00021.07%25.93%$30.85
10/31/201211/16/2012$2.50015.84%35.2%$28.41
02/14/201202/29/2012$2.0007.97%31.89%$25.09

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for HCA

Based on past 10-year performance, here are HCA growth metrics:

Share price CAGR of +15.01%
Dividend CAGR of -10.49%
Using HCA CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

HCA
Current Price$303.62
Start Shares32.94
Start Value$10,000
 
After 10 years:
Final Share Count34.14
Dividends Payment$0.22
Annual Dividends$30
Yield on cost0.30%
Share Price$1,069.25
Total Dividends$567
Final Value$36,507

Estimated Future Value + Dividends - HCA

NOTE: Above numbers are our estimate based on HCA's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

HCA Healthcare, Inc. (HCA) had its IPO on 2011-03-10, and is trader on NYSE stock exchange.

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA website: https://www.hcahealthcare.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial